CALML3 activators refer to a category of chemical compounds that can stimulate or increase the activity of the CALML3 protein. CALML3, an abbreviation for Calmodulin-Like Protein 3, is part of the calmodulin superfamily. Calmodulin proteins are calcium-binding messenger proteins that play pivotal roles in the transduction of calcium signals. They are responsible for mediating a variety of cellular processes by binding to calcium ions and then interacting with a plethora of different target proteins, thereby modulating their activities. The specificity of these proteins, including CALML3, is determined by their unique sequences and structures, which dictate the range of target proteins they can influence and the manner of such interactions.
Activators targeting CALML3 primarily work by enhancing its ability to bind calcium ions or by bolstering its interaction with other target proteins. The underlying mechanisms can vary greatly based on the chemical nature of the activator. Some activators might directly interact with CALML3, altering its conformation and subsequently increasing its affinity for calcium ions. Others might facilitate post-translational modifications of the protein, resulting in its enhanced activity. Additionally, some activators could indirectly amplify CALML3's actions by stabilizing its interactions with partner proteins or by modulating other elements within the calcium signaling pathway. Given the multifaceted nature of cellular signaling networks and the intricate interplay of proteins within these networks, CALML3 activators present an intriguing realm of chemical biology with potential avenues for investigation at both molecular and cellular levels.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is known to activate protein kinase C (PKC) which might influence calcium-mediated pathways and CALML3 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium Butyrate, a histone deacetylase inhibitor, might impact CALML3 expression through epigenetic modulation. |